Short News View Non-AMP

Rheinmetall Shares Crash 17% As Second Outlook Cut Hits German Defence Giant

Published by
Anjali Belgaumkar

Shares of Rheinmetall fell nearly 17% on Thursday after the German defence group lowered its 2026 forecast for the second time since August. The company now expects sales of about €13.2 billion, below its earlier range of €13.7 billion to €14.2 billion, and an operating margin near 18.5% instead of 19%. Rheinmetall blamed delays to the German army’s Arminius order for Boxer armoured vehicles, now expected next year, along with setbacks in artillery ammunition acceptance tests. Advance payments will slip into 2027, hurting its cash conversion goal, and revenue from its partnership with Dutch firm Destinus has also been delayed. RBC called the update clearly negative and said it may add to doubts about traditional defence makers. Third-quarter sales still rose 32% to €3.15 billion. The stock is now down about 46% this year.

Trust with CoinPedia:

CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:

All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:

Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

Anjali Belgaumkar

Writer by choice, CryptoCurrency Writer, and Researcher by chance. Currently, focusing on financial news and analysis, as well as cryptocurrency news and data. One may not call me a crypto “Enthusiast” but trust me I'm getting there.

Recent Posts

Injective Price Prediction: Can INJ Break $10 as Bullish Momentum Returns?

Injective price is showing signs of a recovery after rebounding from the $7 range, with…

November 5, 2026

Asked About XRP Price, David Schwartz Gives The Most Honest Answer Possible

Ripple CTO Emeritus David Schwartz posted a technical update about his XRP Ledger hub on…

November 5, 2026

Can Injective Coin Hit $60 After ETF Approval?

Injective coin search trends are spiking after the Nasdaq stock exchange gave the green light…

November 5, 2026

Bitcoin Tapping $81K Could Be a Trap: Correction Has Not Yet Ended, Says CryptoQuant

Bitcoin’s move toward $81,000 is giving traders hope that the market may be recovering. But…

November 5, 2026

US Stock Market at Risk? Could Democrats’ AI Policy Push Trigger a Bigger Tech Sell-Off?

The US stock market is facing a new risk as Democrats' midterm victories put AI…

November 5, 2026

Should You Buy CVS Stock After 12% Drop? Breakup Plan And Q3 Results

CVS Health will break itself into two separate publicly traded companies by the first half…

November 5, 2026